RHOA mutations are the only frequent GTPase mutations described in PTCL, occurring predominantly in up to 70% of AITL patients as well as 20% of PTCL-NOS and 15% of ATLL cases [93–95,121]. Here, RHOA is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.